Intelligent Bio Solutions Inc.
INBS
$2.15
-$0.05-2.27%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.03M | 3.19M | 3.11M | 2.83M | 2.46M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.03M | 3.19M | 3.11M | 2.83M | 2.46M |
| Cost of Revenue | 1.47M | 1.65M | 1.69M | 2.17M | 1.95M |
| Gross Profit | 1.56M | 1.54M | 1.43M | 659.60K | 514.10K |
| SG&A Expenses | 8.85M | 8.75M | 9.26M | 9.02M | 8.49M |
| Depreciation & Amortization | 1.21M | 1.19M | 1.20M | 1.09M | 1.17M |
| Other Operating Expenses | -421.40K | -441.00K | -424.80K | -385.90K | -419.80K |
| Total Operating Expenses | 13.79M | 13.67M | 13.39M | 12.94M | 12.07M |
| Operating Income | -10.76M | -10.48M | -10.28M | -10.11M | -9.61M |
| Income Before Tax | -10.73M | -10.45M | -10.19M | -10.07M | -13.43M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.73 | -10.45 | -10.19 | -10.07 | -13.43 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 36.70K | 36.10K | 34.10K | 35.50K | 34.50K |
| Net Income | -10.70M | -10.42M | -10.16M | -10.03M | -13.40M |
| EBIT | -10.76M | -10.48M | -10.28M | -10.11M | -9.61M |
| EBITDA | -9.77M | -9.51M | -9.31M | -9.25M | -8.66M |
| EPS Basic | -3.55 | -5.13 | -16.91 | -41.32 | -108.56 |
| Normalized Basic EPS | -2.21 | -3.20 | -10.55 | -25.39 | -39.67 |
| EPS Diluted | -3.55 | -5.13 | -16.91 | -41.32 | -108.56 |
| Normalized Diluted EPS | -2.21 | -3.20 | -10.55 | -25.39 | -39.67 |
| Average Basic Shares Outstanding | 13.47M | 9.88M | 6.26M | 3.33M | 1.34M |
| Average Diluted Shares Outstanding | 13.47M | 9.88M | 6.26M | 3.33M | 1.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
